MARKET

ACIU

ACIU

AC Immune
NASDAQ
3.250
+0.120
+3.83%
After Hours: 3.190 -0.06 -1.85% 19:26 12/29 EST
OPEN
3.135
PREV CLOSE
3.130
HIGH
3.300
LOW
3.135
VOLUME
297.98K
TURNOVER
--
52 WEEK HIGH
4.000
52 WEEK LOW
1.430
MARKET CAP
326.33M
P/E (TTM)
-3.6139
1D
5D
1M
3M
1Y
5Y
1D
My Market Outlook For 2026: Focus On Pharma For Consistent Returns, Potential Skyrocketing Shares
Seeking Alpha · 16h ago
Weekly Report: what happened at ACIU last week (1222-1226)?
Weekly Report · 23h ago
Weekly Report: what happened at ACIU last week (1215-1219)?
Weekly Report · 12/22 09:31
AC Immune: Maintaining 'Buy' Rating On Next Steps For ACI-7104.056 Development In PD
Seeking Alpha · 12/15 19:50
Weekly Report: what happened at ACIU last week (1208-1212)?
Weekly Report · 12/15 09:34
AC Immune Trial Shows Early Signs Immunotherapy May Slow Parkinson's
Benzinga · 12/11 17:47
Promising Advancements in Parkinson’s Treatment: AC Immune’s ACI-7104 Vaccine Shows Groundbreaking Results
TipRanks · 12/11 16:35
BUZZ-U.S. STOCKS ON THE MOVE-Nordson, Walt Disney, Titan Mining
Reuters · 12/11 16:10
More
About ACIU
AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). The Company's pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. Its lead product candidate is Crenezumab, a humanized and monoclonal anti-Abeta antibody for Alzheimer’s disease. It has collaborations with pharmaceutical companies, including Roche/Genentech, Eli Lilly, Biogen, Janssen Pharmaceuticals, Nestle Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.

Webull offers AC Immune SA stock information, including NASDAQ: ACIU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACIU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACIU stock methods without spending real money on the virtual paper trading platform.